These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2580712)

  • 1. Acute effects of antiarrhythmic drugs on stable ventricular premature beats. Controlled comparison of lorcainide and lidocaine.
    Schmidt G; Klein G; Wirtzfeld A
    Eur J Clin Pharmacol; 1985; 27(6):633-6. PubMed ID: 2580712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of intravenous lorcainide with lidocaine for acute therapy of complex ventricular arrhythmias: results of a randomized study with crossover option.
    Anderson JL; Anastasiou-Nana M; Lutz JR; Writer SL
    J Am Coll Cardiol; 1985 Feb; 5(2 Pt 1):333-41. PubMed ID: 3881497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lorcainide for high-frequency ventricular arrhythmia: preliminary results of a short-term double-blind and placebo-controlled crossover study and long-term follow-up.
    Singh SN; DiBianco R; Kostroff LI; Fletcher RD; Cockrell JL
    Am J Cardiol; 1984 Aug; 54(4):22B-28B. PubMed ID: 6380261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lorcainide in stable ventricular extrasystole. A double-blind study with 48-hour continuous ECG recording].
    Buss J; Stegaru B; Geiger S; Gores D; Heene DL
    Dtsch Med Wochenschr; 1984 Nov; 109(48):1829-32. PubMed ID: 6209080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lorcainide in the prophylaxis of ventricular arrhythmias in acute myocardial infarction.
    Leinonen H; Heikkilä J; Sundberg S; Gordin A
    Ann Clin Res; 1984; 16(1):18-22. PubMed ID: 6378045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized double-blind placebo controlled crossover trial documenting oral lorcainide efficacy in suppression of symptomatic ventricular tachyarrhythmias.
    Keefe DL; Peters F; Winkle RA
    Am Heart J; 1982 Apr; 103(4 Pt 1):511-8. PubMed ID: 7039282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous lorcainide for symptomatic ventricular tachyarrhythmias: comparison with lidocaine and oral lorcainide.
    Hohnloser SH; Podrid PJ; Lown B
    Am Heart J; 1988 Apr; 115(4):824-30. PubMed ID: 3354411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral tocainide versus disopyramide: a double-blind, randomized, crossover study of outpatients with stable ventricular premature beats.
    McLaran CJ; Hossack KF; Neilson GH; Siskind V
    J Cardiovasc Pharmacol; 1984; 6(4):657-62. PubMed ID: 6206321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of lorcainide, a new anti-arrhythmic agent.
    Lloyd EA; Workman LJ; Commerford PJ; Mabin TA
    S Afr Med J; 1981 Dec; 60(24):929-31. PubMed ID: 7302777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiarrhythmic effect of lorcainide during chronic treatment.
    Meinertz T; Kasper W; Kersting F; Bechtold H; Just H; Jähnchen E
    Arzneimittelforschung; 1980; 30(9):1593-5. PubMed ID: 7193031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacodynamics of the initiation of antiarrhythmic therapy with lorcainide.
    Winkle RA; Keefe DL; Rodriguez I; Kates RE
    Am J Cardiol; 1984 Feb; 53(4):544-51. PubMed ID: 6198895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic lorcainide therapy for symptomatic premature ventricular complexes: efficacy, pharmacokinetics and evidence for norlorcainide antiarrhythmic effect.
    Mead RH; Keefe DL; Kates RE; Winkle RA
    Am J Cardiol; 1985 Jan; 55(1):72-8. PubMed ID: 2578245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous lorcainide versus lidocaine in the treatment of frequent and complex ventricular arrhythmias.
    Blevins RD; Kerin NZ; Mathias P; Pesola D; Faitel K; Jarandilla R; Garfinkel C; Rubenfire M
    Am Heart J; 1986 Mar; 111(3):447-51. PubMed ID: 3953351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of lorcainide in patients with symptomatic ventricular tachycardia.
    Somberg JC; Butler B; Flowers D; Keefe D; Torres V; Miura D
    Am J Cardiol; 1984 Aug; 54(4):43B-48B. PubMed ID: 6465046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of lorcainide, a new antiarrhythmic drug, in patients with cardiac rhythm disorders.
    Somani P
    Am J Cardiol; 1981 Jul; 48(1):157-63. PubMed ID: 7246437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiarrhythmic effect of lorcainide in patients taking digoxin.
    Giardina EG; Raby K; Saroff AL; Louie-Chu M
    J Clin Pharmacol; 1987; 27(5):378-83. PubMed ID: 3693581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lorcainide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy.
    Eiriksson Ce; Brogden RN
    Drugs; 1984 Apr; 27(4):279-300. PubMed ID: 6373222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lorcainide. A comparative trial with quinidine gluconate in patients with previously untreated ventricular arrhythmias.
    Falk RH; O'Brien JL
    Chest; 1984 Oct; 86(4):537-40. PubMed ID: 6383741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lorcainide for the treatment of refractory ventricular tachycardia: clinical and electrophysiologic results.
    Hanyok JJ; Kluger J; Chow MS; Fieldman A
    J Clin Pharmacol; 1987 Apr; 27(4):278-82. PubMed ID: 3680584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of lorcainide on arrhythmias and survival in patients with acute myocardial infarction: an example of publication bias.
    Cowley AJ; Skene A; Stainer K; Hampton JR
    Int J Cardiol; 1993 Jul; 40(2):161-6. PubMed ID: 8349379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.